Fish oil infusion trial aims to tame dangerous transplant side effect
NCT ID NCT07162688
Summary
This study is testing whether daily intravenous Omega-3 fish oil can help prevent or reduce the severity of acute graft-versus-host disease (aGVHD), a serious and common immune system complication after a donor stem cell transplant. About 30 adult patients receiving this type of transplant will get the Omega-3 infusions daily, starting with their pre-transplant conditioning and continuing for about a month. Researchers will track how many patients develop aGVHD, how severe it is, and look at changes in the immune system and survival rates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT-VERSUS-HOST DISEASE (GVHD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 353000, China
Conditions
Explore the condition pages connected to this study.